Advertisement

Treatment of Renal Cancer

  • J. D. Schmidt
Part of the NATO Advanced Science Institutes Series book series (NSSA, volume 53)

Abstract

The therapy of renal-cell carcinoma has evolved slowly. The earlier reports of increased benefit from radiotherapy, as adjuvant to nephrectomy, were tempered by the improved survival afforded to patients using a radical or extrafascial nephrectomy, (1–6). In this procedure the kidney, with its tumor, is removed along with the accompanying adrenal gland, perinephric fat and perinephric fascia of Gerota. An ipsilateral regional lymphadenectomy, removing tissue from the diaphragmatic crus to the bifurcation of the aorta or vena cava has been espoused by many. At this point, lymphadenectomy can be considered important for more accurate staging and therefore of prognostic value, but it is unlikely that many patients with tumor involvement in the regional lymph nodes (Stage III) are cured by this manoeuvre alone. Pre- or postoperative irradiation is not indicated.

Keywords

Renal Cell Carcinoma Partial Nephrectomy Renal Cancer Radical Nephrectomy Medroxyprogesterone Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    R. H. Flocks and M. C. Kadesky, Malignant neoplasms of the kidney: An analysis of 353 patients followed five years or more, J. Urol. 79:196 (1958).PubMedGoogle Scholar
  2. 2.
    E. W. Riches, The place of radiotherapy in the management of parenchymal carcinoma of the kidney, J. Urol. 95:313 (1966).PubMedGoogle Scholar
  3. 3.
    C. J. Robson, Radical nephrectomy for renal cell carcinoma, J. Urol. 89:37 (1968).Google Scholar
  4. 4.
    C. J. Robson, B. M. Churchill, and W. Anderson, The results of radical nephrectomy for renal cell carcinoma, Trans. Am. Assoc. Genitourin. Surg. 60:122 (1968).PubMedGoogle Scholar
  5. 5.
    D. G. Skinner, R. B. Colvin, C. D. Vermillion, R. C. Pfister, and W. F. Leadbetter, Diagnosis and management of renal cell carcinoma: a clinical and pathologic study of 309 cases, Cancer 28:1165 (1971).PubMedCrossRefGoogle Scholar
  6. 6.
    R. G. Middleton, and A. J. Presto III, Radical thoracoabdominal nephrectomy for renal cell carcinoma, J. Urol. 110: 36 (1973).PubMedGoogle Scholar
  7. 7.
    H. M. Goldstein, H. Medellin, M. T. Beydorn, and S. Wallace, Transcatheter embolization of renal cell carcinoma, Am. J. Roentgenol. 123:557 (1975).CrossRefGoogle Scholar
  8. 8.
    H. J. G. Bloom, Adjuvant therapy for adenocarcinoma of the kidney: Present position and prospects, Br. J. Urol. 45:237 (1973).PubMedCrossRefGoogle Scholar
  9. 9.
    R. Talley, Chemotherapy of adenocarcinoma of the kidney, Cancer 32:1062 (1973).PubMedCrossRefGoogle Scholar
  10. 10.
    K. P. Ramming and J. B. deKernion, Immune RNA therapy for renal carcinoma: Survival and immunologic monitoring, Ann. Surg. 186: 459 (1977).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • J. D. Schmidt
    • 1
  1. 1.University of California Medical CentreSan DiegoUSA

Personalised recommendations